Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 269

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 11
Chunk 269
---
 been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

    Name
     
    Position
     
    Date

    /s/
    Ray Chen
     
    Chief
    Executive Officer, Chief Financial Officer and Director
     
    April 8, 2025
  
    Ray
    Chen
     
    (Principal
    Executive, Financial and Accounting Officer)

    /s/
    Yuquan Wang
     
    Director
     
    April 8, 2025
  
    Yuquan
    Wang

    /s/
    Neil Bush
     
    Director
     
    April 8, 2025
  
    Neil
    Bush

    /s/
    Jonathan McKeage
     
    Director
     
    April 8, 2025
  
    Jonathan
    McKeage

    /s/
    Jeffrey Moseley
     
    Director
     
    April 8, 2025
  
    Jeffrey
    Moseley

40

EXHIBIT
INDEX

    Exhibit
    No.
     
    Description

    1.1
     
    Underwriting Agreement, dated February 15, 2022, between the Company and EF Hutton, division of Benchmark Investments, LLC, as representative of the underwriters named therein (incorporated by reference to Exhibit 1.1 to the Company’s Form 8-K (File No. 001-41289), filed with the SEC on February 24, 2022)
  
    2.1+
     
    Agreement and Plan of Merger, dated September 16, 2024 by and among FutureTech II Acquisition Corp., Longevity Biomedical, Inc., LBI Merger Sub, Inc., and Bradford A. Zakes (in his capacity as Seller Representative) (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-41289), filed with the SEC on September 20, 2024)

    3.1
     
    Amended and Restated Certificate of Incorporation, dated February 17, 2022 (2)
  
    3.2
     
    Certificate of Amendment to the Amended and Restated Certificate of Incorporation, dated August 17, 2023 (3)
  
    3.3
     
    Certificate